Adhesive substrate-modulation of adaptive immune responses

Biomaterials

Volumn 29, Issue 36, 2008, Pages 4736-4750

  Acharya, Abhinav P ^a   Dolgova, Natalia V ^a   Clare Salzler, Michael J ^b   Keselowsky, Benjamin G ^a  

^a University of Florida   (United States)

^b Department of Clinical and Health Psychology   (United States)

Author keywords

Cell adhesion; Extracellular matrix (ECM); Immune response; Immunomodulation; Inflammation; Integrin

Indexed keywords

ADHESION; BIOLOGICAL MATERIALS; CELL CULTURE; DENDRIMERS; ELECTRIC LOAD MANAGEMENT; IMMUNOLOGY; MODULATION; PHOTOLITHOGRAPHY; PROTEINS; TISSUE CULTURE;

CELL ADHESION; EXTRACELLULAR MATRIX (ECM); IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; INTEGRIN;

SUBSTRATES;

COLLAGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; VITRONECTIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC CELL; EX VIVO STUDY; FEMALE; HELPER CELL; NONHUMAN; PRIORITY JOURNAL;

ADHESIVENESS; ANIMALS; BONE MARROW CELLS; CELL ADHESION; CELL COUNT; CELL SHAPE; CYTOKINES; DENDRITIC CELLS; FEMALE; IMMUNITY; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED C57BL; PHENOTYPE; PROTEINS; T-LYMPHOCYTES;

EID: 53449088719     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.08.040     Document Type: Article

References (69)

1. Elamanchili P., Lutsiak C.M., Hamdy S., Diwan M., and Samuel J. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells. J Immunother 30 4 (2007) 378-395
2. Solbrig C.M., Saucier-Sawyer J.K., Cody V., Saltzman W.M., and Hanlon D.J. Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells. Mol Pharm 4 1 (2007) 47-57
3. Matzelle M.M., and Babensee J.E. Humoral immune responses to model antigen co-delivered with biomaterials used in tissue engineering. Biomaterials 25 2 (2004) 295-304
4. Reddy S.T., van d.V., Simeoni E., Angeli V., Randolph G.J., O'Neil C.P., et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 25 10 (2007) 1159-1164
5. Reddy S.T., Swartz M.A., and Hubbell J.A. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol 27 12 (2006) 573-579
6. Babensee J.E. Interaction of dendritic cells with biomaterials. Semin Immunol 20 2 (2008) 101-108
7. Yoshida M., and Babensee J.E. Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation. J Biomed Mater Res A 79 2 (2006) 393-408
8. Tang L., and Eaton J.W. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med 178 6 (1993) 2147-2156
9. Shen M., and Horbett T.A. The effects of surface chemistry and adsorbed proteins on monocyte/macrophage adhesion to chemically modified polystyrene surfaces. J Biomed Mater Res 57 3 (2001) 336-345
10. Anderson J.M., Rodriguez A., and Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 20 2 (2008) 86-100
11. Jenney C.R., and Anderson J.M. Adsorbed serum proteins responsible for surface dependent human macrophage behavior. J Biomed Mater Res 49 4 (2000) 435-447
12. Keselowsky B.G., Bridges A.W., Burns K.L., Tate C.C., Babensee J.E., LaPlaca A.J., et al. Role of plasma fibronectin in the foreign body response to biomaterials. Biomaterials 28 25 (2007) 3626-3631
13. Hunter S.K., Kao J.M., Wang Y., Benda J.A., and Rodgers V.G. Promotion of neovascularization around hollow fiber bioartificial organs using biologically active substances. ASAIO J 45 1 (1999) 37-40
14. Medzhitov R., and Janeway Jr. C.A. Innate immune recognition and control of adaptive immune responses. Semin Immunol 10 5 (1998) 351-353
15. Matzinger P. An innate sense of danger. Semin Immunol 10 5 (1998) 399-415
16. Lambrecht B.N., Salomon B., Klatzmann D., and Pauwels R.A. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 160 8 (1998) 4090-4097
17. Fernandez N.C., Lozier A., Flament C., Ricciardi-Castagnoli P., Bellet D., Suter M., et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5 4 (1999) 405-411
18. Moser M. Balancing life and death. Nat Immunol 5 6 (2004) 559-560
19. Shi Y., Evans J.E., and Rock K.L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425 6957 (2003) 516-521
20. Nakajima H., and Takatsu K. Role of cytokines in allergic airway inflammation. Int Arch Allergy Immunol 142 4 (2007) 265-273
21. Yates S.F., Paterson A.M., Nolan K.F., Cobbold S.P., Saunders N.J., Waldmann H., et al. Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation. J Immunol 179 2 (2007) 967-976
22. Kijima M., Yamaguchi T., Ishifune C., Maekawa Y., Koyanagi A., Yagita H., et al. Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. Proc Natl Acad Sci U S A 105 19 (2008) 7010-7015
23. Fayette J., Dubois B., Vandenabeele S., Bridon J.M., Vanbervliet B., Durand I., et al. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2. J Exp Med 185 11 (1997) 1909-1918
24. Lo J., and Clare-Salzler M.J. Dendritic cell subsets and type I diabetes: focus upon DC-based therapy. Autoimmun Rev 5 6 (2006) 419-423
25. Ranjit S., and Dazhu L. Potential role of dendritic cells for progression of atherosclerotic lesions. Postgrad Med J 82 971 (2006) 573-575
26. Hammad H., and Lambrecht B.N. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 8 3 (2008) 193-204
27. Xu J., Zhou T., and Zhang Y. Role of dendritic cells and chemokines in acute graft-versus-host disease. Front Biosci 13 (2008) 2065-2074
28. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 6 (2002) 673-687
29. Keselowsky B.G., Collard D.M., and Garcia A.J. Surface chemistry modulates focal adhesion composition and signaling through changes in integrin binding. Biomaterials 25 28 (2004) 5947-5954
30. Keselowsky B.G., and Garcia A.J. Quantitative methods for analysis of integrin binding and focal adhesion formation on biomaterial surfaces. Biomaterials 26 4 (2005) 413-418
31. Tate M.C., Garcia A.J., Keselowsky B.G., Schumm M.A., Archer D.R., and LaPlaca M.C. Specific beta1 integrins mediate adhesion, migration, and differentiation of neural progenitors derived from the embryonic striatum. Mol Cell Neurosci 27 1 (2004) 22-31
32. Keselowsky B.G., Wang L., Schwartz Z., Garcia A.J., and Boyan B.D. Integrin alpha(5) controls osteoblastic proliferation and differentiation responses to titanium substrates presenting different roughness characteristics in a roughness independent manner. J Biomed Mater Res A 80 3 (2007) 700-710
33. Lan M.A., Gersbach C.A., Michael K.E., Keselowsky B.G., and Garcia A.J. Myoblast proliferation and differentiation on fibronectin-coated self assembled monolayers presenting different surface chemistries. Biomaterials 26 22 (2005) 4523-4531
34. Manfred B., Lutz N.K., Alexandra L.J., Ogilvie S.R., and Franz K. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223 (1999) 77-92
35. Steinman R.M., and Nussenzweig M.C. Dendritic cells: features and functions. Immunol Rev 53 (1980) 127-147
36. Riedl E., Stockl J., Majdic O., Scheinecker C., Knapp W., and Strobl H. Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. Blood 96 13 (2000) 4276-4284
37. Lord R.S., and Bobryshev Y.V. Clustering of dendritic cells in athero-prone areas of the aorta. Atherosclerosis 146 1 (1999) 197-198
38. Agren M.S., and Werthén M. The extracellular matrix in wound healing: a closer look at therapeutics for chronic wounds. Int J Low Extrem Wounds 6 2 (2007) 82-97
39. Yoo J.K., Cho J.H., Lee S.W., and Sung Y.C. IL-12 provides proliferation and survival signals to murine CD4 + T cells through phosphatidylinositol 3-kinase/Akt signaling pathway. J Immunol 169 7 (2002) 3637-3643
40. Creusot R.J., Yaghoubi S.S., Kodama K., Dang D.N., Dang V.H., Breckpot K., et al. Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice. Clin Immunol 127 2 (2008) 176-187
41. Sanna A., Fois M.L., Arru G., Huang Y.M., Link H., Pugliatti, et al. Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis. Clin Exp Immunol 143 2 (2006) 357-362
42. Leech M.D., and Grencis R.K. Induction of enhanced immunity to intestinal nematodes using IL-9-producing dendritic cells. J Immunol 176 4 (2006) 2505-2511
43. Keselowsky B.G., Collard D.M., and Garcia A.J. Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proc Natl Acad Sci U S A 102 17 (2005) 5953-5957
44. Keselowsky B.G., Collard D.M., and Garcia A.J. Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion. J Biomed Mater Res A 66 2 (2003) 247-259
45. Kohl K., Schnautz S., Pesch M., Klein E., Aumailley M., Bieber T., et al. Subpopulations of human dendritic cells display a distinct phenotype and bind differentially to proteins of the extracellular matrix. Eur J Cell Biol 86 11-12 (2007) 719-730
46. Brand U., Bellinghausen I., Enk A.H., Jonuleit H., Becker D., Knop J., et al. Influence of extracellular matrix proteins on the development of cultured human dendritic cells. Eur J Immunol 28 5 (1998) 1673-1680
47. Nencioni A., and Brossart P. Cellular immunotherapy with dendritic cells in cancer: current status. Stem Cells 22 4 (2004) 501-513
48. Nencioni A., Grunebach F., Schmidt S.M., Muller M.R., Boy D., Patrone F., et al. The use of dendritic cells in cancer immunotherapy. Crit Rev Oncol Hematol 65 3 (2008) 191-199
49. Xiao B.G., Huang Y.M., and Link H. Dendritic cell vaccine design: strategies for eliciting peripheral tolerance as therapy of autoimmune diseases. BioDrugs 17 2 (2003) 103-111
50. Xiao B.G., Huang Y.M., and Link H. Tolerogenic dendritic cells: the ins and outs of outcome. J Immunother 29 5 (2006) 465-471
51. Xia C.Q., Peng R., Beato F., and Clare-Salzler M.J. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand J Immunol 62 1 (2005) 45-54
52. Matzinger P. Friendly and dangerous signals: is the tissue in control?. Nat Immunol 8 1 (2007) 11-13
53. Mora J.R., Bono M.R., Manjunath N., Weninger W., Cavanagh L.L., Rosemblatt M., et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424 6944 (2003) 88-93
54. Johansson C., and Kelsall B.L. Phenotype and function of intestinal dendritic cells. Semin Immunol 17 4 (2005) 284-294
55. Lu L., Rudert W.A., Qian S., McCaslin D., Fu F., Rao A.S., et al. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med 182 2 (1995) 379-387
56. Dubey C., Croft M., and Swain S.L. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J Immunol 155 1 (1995) 45-57
57. Brown K.A., Bedford P., Macey M., McCarthy D.A., Leroy F., Vora A.J., et al. Human blood dendritic cells: binding to vascular endothelium and expression of adhesion molecules. Clin Exp Immunol 107 3 (1997) 601-607
58. Sung S.S., Fu S.M., Rose Jr. C.E., Gaskin F., Ju S.T., and Beaty S.R. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol 176 4 (2006) 2161-2172
59. Dalgaard J., Beckstrom K.J., Jahnsen F.L., and Brinchmann J.E. Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsets. J Leukoc Biol 77 5 (2005) 689-698
60. Harui A., Roth M.D., Vira D., Sanghvi M., Mizuguchi H., and Basak S.K. Adenoviral-encoded antigens are presented efficiently by a subset of dendritic cells expressing high levels of alpha(v)beta3 integrins. J Leukoc Biol 79 6 (2006) 1271-1278
61. Kempf M., Mandal B., Jilek S., Thiele L., Voros J., Textor M., et al. Improved stimulation of human dendritic cells by receptor engagement with surface-modified microparticles. J Drug Target 11 1 (2003) 11-18
62. Maestroni G.J., and Mazzola P. Langerhans cells beta 2-adrenoceptors: role in migration, cytokine production, Th priming and contact hypersensitivity. J Neuroimmunol 144 1-2 (2003) 91-99
63. Li H., Oliver T., Jia W., and He Y.W. Efficient dendritic cell priming of T lymphocytes depends on the extracellular matrix protein mindin. EMBO J 25 17 (2006) 4097-4107
64. Hamakawa M., Sugihara A., Okamoto H., and Horio T. Ultraviolet B radiation suppresses Langerhans cell migration in the dermis by down-regulation of alpha4 integrin. Photodermatol Photoimmunol Photomed 22 3 (2006) 116-123
65. Puig-Kroger A., Sanz-Rodriguez F., Longo N., Sanchez-Mateos P., Botella L., Teixido J., et al. Maturation-dependent expression and function of the CD49d integrin on monocyte-derived human dendritic cells. J Immunol 165 8 (2000) 4338-4345
66. Ammon C., Meyer S.P., Schwarzfischer L., Krause S.W., Andreesen R., and Kreutz M. Comparative analysis of integrin expression on monocyte-derived macrophages and monocyte-derived dendritic cells. Immunology 100 3 (2000) 364-369
67. Dutton R.W. Further studies of stimulation of dna synthesis in cultures of spleen cell suspensions by homologous cells in inbred strains of mice and rats. J Exp Med 122 4 (1965) 759-770
68. Dutton R.W. Spleen cell proliferation in response to homologous antigens studied in congenic resistant strains of mice. J Exp Med 123 4 (1966) 665-671
69. Schwarz M.R. Mixed lymphocyte reaction: an in vitro test for tolerance. J Exp Med 127 5 (1968) 879-893